Viewing Study NCT06843434


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-03-05 @ 10:35 PM
Study NCT ID: NCT06843434
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2025-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Microsatellite Stable Rectal Carcinoma View
None Locally Advanced Rectal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Microsatellite Stable Rectal Carcinoma View
None mismatch repair proficient locally advanced rectal adenocarcinoma View
None locally advanced rectal adenocarcinoma View
None microsatellite stable locally advanced rectal adenocarcinoma View
None Memorial Sloan Kettering Cancer Center View
None 24-389 View